Increased forearm bone mineral content after bromocriptine treatment in hyperprolactinemia

Maria P. Caraceni, Enzo Corghi, Sergio Ortolani, Silvano Casazza, Alberto D'Alberton, Tiziano Motta

Research output: Contribution to journalArticle


We studied 15 hyperprolactinemic women to evaluate possible modifications of bone mineral content after pharmacological treatment. Patients received a dopamine agonist (bromocriptine) for six months after which there was a significant decrease of prolactin plasma levels (P

Original languageEnglish
Pages (from-to)687-689
Number of pages3
JournalCalcified Tissue International
Issue number6
Publication statusPublished - Nov 1985



  • Bone mineral content
  • Bromocriptine
  • Hyperprolactinemia

ASJC Scopus subject areas

  • Endocrinology
  • Orthopedics and Sports Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this